Dosage
2mg/packet
Initial Oral Dosage
Medically reviewed by Drugs
The initial
Approval: 1994
Used in combination with other immunosuppressants for prevention of renal allograft rejection
Approval: 1994
Tacrolimus (Prograf) is a medication used to prevent organ rejection after an organ transplant
De novo kidney transplant
e
It is supplied by Ascend Laboratories LLC
Changes between tacrolimus immediate-release and extended-release dosage forms must occur under physician supervision [see Warnings and Precautions (5
The initial oral tacrolimus capsules dosage recommendations for adult patients with kidney, liver, or heart transplants and whole blood trough concentration
3)]
For oral dosage form (extended-release tablets): To prevent kidney transplant rejection: Adults—Dose is based on body weight and must be determined by your doctor
The dosage is based on your weight, medical condition, lab tests (such as tacrolimus trough levels), response to treatment, and previous dose of tacrolimus (if switching from the form of this immediate-release tacrolimus drug product
Open up the prescribed number of packets for your dose and mix the granules in a cup with 1 to 2 tablespoons (15 to 30 milliliters) of room temperature water and stir well
3)]
2 mg/kg/day, divided in two doses, administered every 12 hours In adult patients receiving tacrolimus immediate-release products in combination with MMF (n=15,478) or tacrolimus immediate
Commercially available forms of tacrolimus include immediate- and extended-release 0
5 or 1 mg/mL may also be compounded by combining the immediate-release capsules with suspending and sweetening agents